AI assistant
INSMED Inc — Director's Dealing 2025
Jan 11, 2025
30150_dirs_2025-01-10_e80a00ef-51ef-42fa-8426-e2f4d247cd86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-01-07
Reporting Person: Lewis William (Director, Chair and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-07 | Common Stock | S | 8218 | $66.02 | Disposed | 376742 | Direct |
| 2025-01-08 | Common Stock | S | 3999 | $65.96 | Disposed | 372743 | Direct |
| 2025-01-08 | Common Stock | A | 22824 | — | Acquired | 395567 | Direct |
| 2025-01-10 | Common Stock | S | 2978 | $63.36 | Disposed | 392589 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-08 | Stock Option (right to buy) | $65.72 | A | 109490 | Acquired | 2035-01-08 | Common Stock (109490) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 233924 | Indirect |
| Common Stock | 50500 | Indirect |
Footnotes
F1: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.
F2: This is the weighted average sales price representing 8,218 shares sold at prices ranging from $66.00 to $66.05 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F4: Each RSU was granted on January 8, 2025 for no consideration.
F5: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.